Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LY-3971297 by Eli Lilly and Co for Hypertension: Likelihood of Approval
LY-3971297 is under clinical development by Eli Lilly and Co and currently in Phase I for Hypertension. According to GlobalData,...
Data Insights
LY-3971297 by Eli Lilly and Co for Obesity: Likelihood of Approval
LY-3971297 is under clinical development by Eli Lilly and Co and currently in Phase I for Obesity. According to GlobalData,...